Swanbridge Capital logo

Swanbridge Capital

Europe, Zuid-Holland, The Netherlands, Rotterdam

Description

Swanbridge Capital is a Rotterdam based venture capital fund.

Investor Profile

Swanbridge Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in The Netherlands.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Seed (67%)
  • Series A (33%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Swanbridge Capital frequently co-invest with?

Thuja Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 1
Curie Capital
North America, Missouri, United States, Netherlands
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
InnovationQuarter
Europe, Zuid-Holland, The Netherlands, The Hague
Co-Investments: 1
Co-Investments: 1
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 1
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 1
Erasmus MC
Europe, Zuid-Holland, The Netherlands, Rotterdam
Co-Investments: 1
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Swanbridge Capital?

Pan Cancer

Rotterdam, Zuid-Holland, The Netherlands

Pan Cancer exploits 20 years of pioneering research in the field of adoptive T-cell therapies.

BiotechnologyLife ScienceTherapeutics
SeedJul 11, 2024
Amount Raised: $4,608,685
Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056
Allero Therapeutics

Rotterdam, Zuid-Holland, The Netherlands

Allero Therapeutics is a biopharmaceutical company.

BiotechnologyPharmaceutical
SeedApr 17, 2019

Find More Investors Like Swanbridge Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Swanbridge Capital | Pipeseed